Why oncology experts are pushing for more diversity in cancer clinical trials

Why oncology experts are pushing for more diversity in cancer clinical trials

Precision medicine holds significant promise for cancer care but may be out of reach for minority populations due to a lack of diversity among participants in clinical trials, experts say.




Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Foundation, Inc. All Rights Reserved.

Built on Dec 18, 2024 at 12:33pm